Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending October 1, 2004. The report primarily details corporate governance activities, including changes in directors' share interests, share repurchase transactions, and non-executive director share allocations. The filing does not contain financial performance results for a specific quarter or fiscal year.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margins, debt, or liquidity figures. The only financial data present relates to specific share transaction prices and volumes:
- Share Repurchase Price: 1,210.67 pence per share.
- Director ISA Purchase Price: £12.19 per Ordinary Share.
- Director ShareReward Plan Price: £12.20 per Ordinary Share.
- US Retirement Fund ADR Average Price: $43.03.
Material Changes
The following material changes in capital structure and director interests were reported:
- Treasury Shares: The Company purchased 525,000 Ordinary shares on September 30, 2004. Following this transaction, total Treasury shares held increased to 48,553,000.
- Shares in Issue: Excluding Treasury shares, the Company has 5,886,720,490 shares in issue.
- US Retirement Fund: The number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan decreased from 19,099,769 to 19,031,468 due to fund movements.
- Director Holdings: Various directors (including Mr. J D Coombe, Mrs. G A Coombe, and Sir Peter Job) acquired shares via ISA or ShareReward plans. Non-executive directors received provisional share allocations for the period of July 1 to September 30, 2004.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, risk factors, or contingencies. It is a procedural report regarding share ownership and repurchases.
Key Facts for Investor Verification
- Verify the impact of the 525,000 share buyback on the total Treasury share count (now 48,553,000).
- Confirm the total number of shares in issue (5,886,720,490) excluding Treasury shares.
- Note the specific share prices paid by directors (£12.19 and £12.20) compared to the market price at the time of the repurchase (1,210.67 pence).
- Review the reduction in ADR holdings within the US Retirement Savings Plan.